Echo Pharmaceuticals B.V.
Improve the quality of life of patients by developing novel medicines, with a special focus on cannabinoids as active ingredients.
Echo Pharmaceuticals is a privately owned specialist, research-based pharmaceutical company aiming to meet patient needs in a wide rage of therapeutic areas. The development program focus on a product portfolio of cannabinoid based medicines and drug delivery technologies. Our leading drug candidate, Namisol®, is the first oral tablet containing natural and pure THC (+98%) that is currently in phase II trials for MS, Chronic pain and AD.